Frazier Lifesciences Acquisition Corp. FLAC
$ 9.87
1.82%
Quarterly report 2022-Q3
added 11-09-2022
Country |
USA |
IPO year |
2021 |
Industry |
- |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
- |
Employees in the company |
- |
Shares |
- |
Market Cap[1] |
$ 175 M |
EBITDA (LTM) |
$ -5 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.